Loading…
Paradoxical psoriasis following anti–TNF therapy in ankylosing spondylitis: A population-based cohort study
[...]we did not evaluate some variables that may contribute to the development of psoriasiform disease including smoking status and obesity. [...]patients with AS with higher disease activity could be assigned to the group treated with anti–TNF-α agents, and we cannot exclude the possibility that th...
Saved in:
Published in: | Journal of allergy and clinical immunology 2018-09, Vol.142 (3), p.1001-1003.e2 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]we did not evaluate some variables that may contribute to the development of psoriasiform disease including smoking status and obesity. [...]patients with AS with higher disease activity could be assigned to the group treated with anti–TNF-α agents, and we cannot exclude the possibility that those patients might be associated more with psoriasis. [...]this study confirmed that the risk of new-onset psoriasis and PPP was significantly increased in patients with AS receiving anti–TNF agents. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2018.05.015 |